Patent: 9,993,491
✉ Email this page to a colleague
Summary for Patent: 9,993,491
Title: | Guanine riboswitch binding compounds and their use as antibiotics |
Abstract: | The present invention includes novel compounds and pharmaceutically acceptable formulations of said compounds which exhibit antibiotic activity against microorganisms bearing a guanine riboswitch that controls the expression of the guaA gene, including organisms which are resistant to certain antibiotic families, and which are useful as antibacterial agents for treatment or prophylaxis of bacterial infections in animals or in humans, in particular but not limited to infections of the mammary gland, or their use as antiseptics, agents for sterilization or disinfection. |
Inventor(s): | Mulhbacher; Jerome (Sherbrooke, CA), Lafontaine; Daniel (Sherbrooke, CA), Malouin; Francois (Eastman, CA), Allard; Marianne (Sherbrooke, CA), Marsault; Eric (Sherbrooke, CA) |
Assignee: | SOCPRA--SCIENCES ET GENIE S.E.C. (Sherbrooke, CA) |
Application Number: | 14/616,164 |
Patent Claims: | see list of patent claims |
Details for Patent 9,993,491
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emergent Biodefense Operations Lansing Llc | BIOTHRAX | anthrax vaccine adsorbed | Injection | 103821 | 11/12/1998 | ⤷ Try a Trial | 2029-06-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |